Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
08 2023
Historique:
received: 09 11 2022
accepted: 26 04 2023
revised: 17 04 2023
medline: 7 8 2023
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

FINCA syndrome [MIM: 618278] is an autosomal recessive multisystem disorder characterized by fibrosis, neurodegeneration and cerebral angiomatosis. To date, 13 patients from nine families with biallelic NHLRC2 variants have been published. In all of them, the recurrent missense variant p.(Asp148Tyr) was detected on at least one allele. Common manifestations included lung or muscle fibrosis, respiratory distress, developmental delay, neuromuscular symptoms and seizures often followed by early death due to rapid disease progression.Here, we present 15 individuals from 12 families with an overlapping phenotype associated with nine novel NHLRC2 variants identified by exome analysis. All patients described here presented with moderate to severe global developmental delay and variable disease progression. Seizures, truncal hypotonia and movement disorders were frequently observed. Notably, we also present the first eight cases in which the recurrent p.(Asp148Tyr) variant was not detected in either homozygous or compound heterozygous state.We cloned and expressed all novel and most previously published non-truncating variants in HEK293-cells. From the results of these functional studies, we propose a potential genotype-phenotype correlation, with a greater reduction in protein expression being associated with a more severe phenotype.Taken together, our findings broaden the known phenotypic and molecular spectrum and emphasize that NHLRC2-related disease should be considered in patients presenting with intellectual disability, movement disorders, neuroregression and epilepsy with or without pulmonary involvement.

Identifiants

pubmed: 37188825
doi: 10.1038/s41431-023-01382-0
pii: 10.1038/s41431-023-01382-0
pmc: PMC10400545
doi:

Substances chimiques

NHLRC2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-917

Subventions

Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG011758
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007526
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Nucleic Acids Res. 2021 Jul 2;49(W1):W446-W451
pubmed: 33893808
Nature. 2018 Mar 22;555(7697):463-468
pubmed: 29539633
Cell Death Dis. 2017 Dec 14;8(12):3218
pubmed: 29242562
J Hum Genet. 2020 Oct;65(10):911-915
pubmed: 32435055
Mol Genet Genomic Med. 2022 Apr;10(4):e1899
pubmed: 35255187
Genesis. 2022 Mar;60(3):e23470
pubmed: 35258166
Clin Genet. 2021 Oct;100(4):453-461
pubmed: 34165204
Genome Med. 2017 Mar 21;9(1):26
pubmed: 28327206
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Nat Genet. 2018 Dec;50(12):1716-1727
pubmed: 30397336
Acta Neuropathol. 2018 May;135(5):727-742
pubmed: 29423877
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
PLoS One. 2018 Aug 23;13(8):e0202391
pubmed: 30138417
Nat Methods. 2020 Feb;17(2):184-192
pubmed: 31819266
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Hum Genet. 1986 Aug;73(4):320-6
pubmed: 3017841
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
J Med Genet. 2022 Jul;59(7):662-668
pubmed: 34379057
Nucleic Acids Res. 2022 Jul 5;50(W1):W83-W89
pubmed: 35489060

Auteurs

Henrike L Sczakiel (HL)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.
Max Planck Institute for Molecular Genetics, RG Development & Disease, Ihnestr. 63-73, 14195, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.

Max Zhao (M)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.
Max Planck Institute for Molecular Genetics, RG Development & Disease, Ihnestr. 63-73, 14195, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Brigitte Wollert-Wulf (B)

Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany.
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, 13125, Germany.
Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, 13125, Germany.

Magdalena Danyel (M)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany.

Nadja Ehmke (N)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Corinna Stoltenburg (C)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Sozialpädiatrisches Zentrum Neuropädiatrie, Augustenburger Platz 1, 13353, Berlin, Germany.

Nadirah Damseh (N)

Department of Pediatrics and Genetics, Al Makassed Hospital and Al-Quds University, Jerusalem, Palestine.

Motee Al-Ashhab (M)

Department of Pediatrics and Genetics, Al Makassed Hospital and Al-Quds University, Jerusalem, Palestine.

Tugce B Balci (TB)

Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, Western University, London, ON, Canada.

Matthew Osmond (M)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.

Andrea Andrade (A)

Division of Pediatric Neurology, London Health Sciences Centre, Western University, London, ON, Canada.

Jens Schallner (J)

Department of Sozialpaediatrisches Zentrum, Klinik fuer Kinder und Jugendmedizin, Universitaetsklinikum Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.

Joseph Porrmann (J)

Institute for Clinical Genetics, Universitätsklinikum, Technischen Universität Dresden, Dresden, Germany.

Kimberly McDonald (K)

Pediatric Neurology, University of Mississippi Medical Center, Jackson, MS, USA.

Mingjuan Liao (M)

GeneDx, LLC, Gaithersburg, MD, 20877, USA.

Henry Oppermann (H)

Institute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.

Konrad Platzer (K)

Institute of Human Genetics, University of Leipzig Medical Center, 04103, Leipzig, Germany.

Nadine Dierksen (N)

Evangelisches Krankenhaus Oberhausen, Oberhausen, Germany.

Majid Mojarrad (M)

Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Atieh Eslahi (A)

Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Behnaz Bakaeean (B)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Daniel G Calame (DG)

Section of Pediatric Neurology and Developmental Neurosciences, Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Texas Children's Hospital, Houston, TX, 77030, USA.

James R Lupski (JR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Texas Children's Hospital, Houston, TX, 77030, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA.

Zahra Firoozfar (Z)

Palindrome, Isfahan, Iran.

Seyed Mohammad Seyedhassani (SM)

Dr. Seyedhassani Medical Genetic Center, Yazd, Iran.

Seyed Ahmad Mohammadi (SA)

Meybod Genetics Research Center, Yazd, Iran.
Yazd Welfare Organisation, Yazd, Iran.

Najwa Anwaar (N)

Department of Developmental - Behavioral Pediatrics, University of Child Health Sciences and The Children's Hospital, Lahore, Pakistan.

Fatima Rahman (F)

Department of Developmental - Behavioral Pediatrics, University of Child Health Sciences and The Children's Hospital, Lahore, Pakistan.

Dominik Seelow (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.
Bioinformatics and Translational Genetics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Martin Janz (M)

Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, 13125, Germany.
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, 13125, Germany.
Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, 13125, Germany.

Denise Horn (D)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany.

Reza Maroofian (R)

Department of Neuromuscular Diseases, University College London, Queen Square, Institute of Neurology, London, WC1N 3BG, UK.

Felix Boschann (F)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institut für Medizinische Genetik und Humangenetik, Augustenburger Platz 1, 13353, Berlin, Germany. felix.boschann@charite.de.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. felix.boschann@charite.de.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Charitéplatz 1, 10117, Berlin, Germany. felix.boschann@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH